Valuation: Electromed, Inc.

Market Cap 326M 279M 262M 239M 451M 31.05B 455M 3.09B 1.2B 15.67B 1.22B 1.2B 51.89B P/E 2027 *
26.6x
P/E 2028 * 22.2x
Enterprise Value 326M 279M 262M 239M 451M 31.05B 455M 3.09B 1.2B 15.67B 1.22B 1.2B 51.89B EV / Sales 2027 *
3.9x
EV / Sales 2028 * 3.56x
Free-Float
82.82%
Yield 2027 *
-
Yield 2028 * -
1 day-10.23%
1 week-16.52%
Current month-16.23%
1 month-14.40%
3 months-10.91%
6 months+41.75%
Current year+17.17%
1 week 33.34
Extreme 33.34
41.28
1 month 33.34
Extreme 33.34
43.74
Current year 23.01
Extreme 23.01
47.4
1 year 23.01
Extreme 23.01
47.4
3 years 9.53
Extreme 9.53
47.4
5 years 8.75
Extreme 8.75
47.4
10 years 3.38
Extreme 3.38
47.4
Manager TitleAgeSince
Chief Executive Officer 61 01/07/2023
Director of Finance/CFO 44 14/11/2022
Compliance Officer - 01/09/2023
Director TitleAgeSince
Chairman 69 01/07/2023
Director/Board Member 76 21/11/2014
Director/Board Member 57 15/08/2019
Date Insider Type Main position Quantity % Market Cap.
30/6/26 Tax

Chief Financial Officer

-674 0.0081%
1/12/25 Free

Director

3,000 0.0360%
1/12/25
Summers Value Partners LLC
OtherCompany 0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-10.07%-16.52%+65.15%+207.39% 326M
+0.40%+2.35%+28.56%+15.19% 232B
+0.16%+1.56%+4.14%-17.86% 152B
-0.28%-7.09%-22.08%+22.57% 131B
-4.45%-7.78%-54.92%-10.83% 72.26B
-0.31%-1.20%-16.38%-13.66% 51.57B
+1.11%-1.80%+11.50%+19.18% 52.38B
-0.18%-1.06%+29.98%+28.22% 43.71B
+0.15%-1.24%+38.67%+45.91% 40.72B
+0.82%+9.68%+127.74%+42.13% 33.97B
Average -1.23%+3.52%+21.24%+33.82% 81.04B
Weighted average by Cap. -0.14%+3.71%+9.13%+9.75%

Financials

2027 *2028 *
Net sales 83.6M 71.64M 67.12M 61.31M 116M 7.97B 117M 792M 308M 4.02B 314M 307M 13.32B 91.5M 78.41M 73.47M 67.11M 127M 8.72B 128M 867M 337M 4.4B 344M 336M 14.57B
Net income 12.83M 11M 10.3M 9.41M 17.76M 1.22B 17.94M 122M 47.32M 617M 48.19M 47.14M 2.04B 15.3M 13.11M 12.28M 11.22M 21.18M 1.46B 21.39M 145M 56.41M 736M 57.45M 56.2M 2.44B
Net Debt - -
Logo Electromed, Inc.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Employees
179
Date Price Change Volume
27/08/26 USD 33.82 -14.03% 74,194
25/08/26 USD 39.34 -2.36% 93,261
24/08/26 USD 40.29 +2.13% 58,539
21/08/26 USD 39.45 -1.37% 157,116
20/08/26 USD 40.00 -2.13% 40,032
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
39.34USD
Average target price
40.33USD
Spread / Average Target
+2.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ELMD Stock